-
Patient Advocates Go to Washington
Patient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.
by Marci A. Landsmann
-
The Affordable Care Act and Cancer Patients
Cancer survivors tell their stories and researchers take a broad view.
by Kevin McLaughlin
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Q&A
Rolling Up Her SleevesPrincess Dina Mired of Jordan will be the first Arab president of the Union for International Cancer Control.
by Sue Rochman
-
Get Involved
Outdoor HealingAn outdoor adventure camp benefits cancer survivors of all ages.
by Lindsey Konkel
-
Forward Look
Inside the 21st Century Cures ActLegislation brings high hopes for cancer research.
by Stephen Ornes
-
Survivor Profile
Going Full BoreSusan Leighton, a 19-year survivor, is a powerful advocate for ovarian cancer research. Her advocacy, which began locally in northern Alabama, has reached the National Cancer Institute and the Department of Defense.
by Sue Rochman
-
Get Involved
Diversifying DonorsA diverse donor pool benefits patients in need of bone marrow transplants.
by Lindsey Konkel
-
Forward Look
The Impact of Rising Drug CostsHigher prices of oral medicines may affect financial well-being.
by Chris Palmer
-
Forward Look
World Cancer Day: Accelerating ProgressImage courtesy of the Union for International Cancer Control February 4 is World Cancer Day, an international effort to increase cancer awareness and education to reduce preventable cancer deaths. World Cancer Day 2017 marks the midpoint of a three-year campaign, “We Can. I Can.” The overarching goal has been to encourage everyone, everywhere—from government health organizations […]
by Sue Rochman
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff